Mexiletine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2132 publications

T-World Virtual Human Cardiomyocyte. II. Organ-Scale Simulations and Applications.

T-World Virtual Human Cardiomyocyte. II. Organ-Scale Simulations and Applications.

Journal: Circulation research

Published: April 08, 2026

Common Genetic Variants of The Cardiac Sodium Channel Alter Patient Response to Class 1b Antiarrhythmics.

Common Genetic Variants of The Cardiac Sodium Channel Alter Patient Response to Class 1b Antiarrhythmics.

Journal: bioRxiv : the preprint server for biology

Published: February 06, 2026

A Simple Dual-Track HPLC-UV Methodology for Monitoring Primary Antiarrhythmic Drugs and Their Active Metabolites in Serum.

A Simple Dual-Track HPLC-UV Methodology for Monitoring Primary Antiarrhythmic Drugs and Their Active Metabolites in Serum.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 16, 2026

Emergency pharmacotherapy in rhythmology

Emergency pharmacotherapy in rhythmology

Journal: Herzschrittmachertherapie & Elektrophysiologie

Published: December 11, 2025

ECG artefact or life-threatening arrhythmia? A neonatal presentation of Long QT syndrome type 3 with a de novo SCN5A mutation.

ECG artefact or life-threatening arrhythmia? A neonatal presentation of Long QT syndrome type 3 with a de novo SCN5A mutation.

Journal: Cardiology in the young

Published: December 11, 2025

Stability assessment of a novel 3D-printed oral dosage form of Mexiletine Hydrochloride: a six-month shelf-life study.

Stability assessment of a novel 3D-printed oral dosage form of Mexiletine Hydrochloride: a six-month shelf-life study.

Journal: Pharmaceutical development and technology

Published: November 15, 2025

Reductant-Controlled Access to Sulfinamides from Aliphatic Primary Amines.

Reductant-Controlled Access to Sulfinamides from Aliphatic Primary Amines.

Journal: Organic letters

Published: November 03, 2025

Unlocking the catalytic potential of transaminase: A two-decade evolution toward green and scalable biocatalysis.

Unlocking the catalytic potential of transaminase: A two-decade evolution toward green and scalable biocatalysis.

Journal: Bioorganic chemistry

Published: October 30, 2025

Repositioning lidocaine as a TMEM16A Ca2+-activated Cl- channel blocker for the treatment of pulmonary arterial hypertension.

Repositioning lidocaine as a TMEM16A Ca2+-activated Cl- channel blocker for the treatment of pulmonary arterial hypertension.

Journal: The Journal of pharmacology and experimental therapeutics

Published: October 08, 2025

Advanced cardiotoxicity profiling using field potential imaging with UHD-CMOS-MEA in human iPSC-derived cardiomyocytes.

Advanced cardiotoxicity profiling using field potential imaging with UHD-CMOS-MEA in human iPSC-derived cardiomyocytes.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: September 30, 2025

Mexiletine as Adjunctive Therapy in Atrial Fibrillation Following Dofetilide Treatment Failure.

Mexiletine as Adjunctive Therapy in Atrial Fibrillation Following Dofetilide Treatment Failure.

Journal: Circulation. Arrhythmia and electrophysiology

Published: September 25, 2025

Long-Term Outcomes and Post-Ablation Medication De-Escalation After Catheter Ablation for Premature Ventricular Complexes: A Nationwide Cohort Study.

Long-Term Outcomes and Post-Ablation Medication De-Escalation After Catheter Ablation for Premature Ventricular Complexes: A Nationwide Cohort Study.

Journal: International journal of general medicine

Published: September 18, 2025

Showing 1-12 of 2,132

Last Updated: 04/28/2026